← Back to headlines
Wegovy and Ozempic owner dealt blow as next-gen weight-loss drug is labelled ‘obsolete’
Novo Nordisk’s shares fall sharply after testing of CagriSema falls short of investors’ expectations
23 Feb, 14:26 — 23 Feb, 14:26
ℹOnly 1 source covers this story
